Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/160
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/160
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ANJAY RASTOGI

Listed Specialty: Nephrology
200 MEDICAL PLAZA, #365,420,120,530, LOS ANGELES, CA, 90095-0001

2018 Payments: At a Glance

398

payments

$321,172

payment total

14

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
 84 $185K
Travel and Lodging
 163 $67,972
Consulting
 18 $49,960
Food and Beverage
 130 $10,400
Charitable Contribution
 1 $5,000
Honoraria
 1 $2,375
Education
 1 $300

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
PARSABIV

drug

 $76,068
FABRAZYME

drug

 $72,685
JYNARQUE

drug

 $44,985
VELPHORO

drug

 $37,474
Payments with no listed product

N/A

 $23,893
VELTASSA

drug

 $22,526
NO PRODUCT DISCUSSED

drug

 $12,263
DUZALLO

drug

 $8,886
RENAL - NON PRODUCT RELATED

drug

 $6,182
NOT PRODUCT RELATED

device

 $5,482
VELOPHORO

drug

 $4,444
XARELTO

drug

 $3,407
REPATHA

drug

 $2,075
FERAHEME

drug

 $800
FABRY-DISEASE

drug

 $19
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Feb 20, 2018 $9,988 No Listed Product Travel and Lodging ASTRAZENECA PHARMACEUTICALS LP
Oct 19, 2018 $5,856 FABRAZYME Consulting GENZYME CORPORATION
Jun 5, 2018 $5,000 No Listed Product Charitable Contribution KADMON CORPORATION LLC The UCLA Foundation
Mar 9, 2018 $4,200 VELTASSA Consulting RELYPSA, INC.
Dec 3, 2018 $4,070 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Dec 13, 2018 $4,070 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Feb 8, 2018 $4,070 NO PRODUCT DISCUSSED Consulting GENZYME CORPORATION
Apr 26, 2018 $3,890 No Listed Product Consulting ASTRAZENECA UK LIMITED
Jan 30, 2018 $3,885 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Mar 6, 2018 $3,885 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Jan 23, 2018 $3,885 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Oct 10, 2018 $3,885 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Jan 9, 2018 $3,885 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Jan 11, 2018 $3,700 NO PRODUCT DISCUSSED Consulting GENZYME CORPORATION
Oct 24, 2018 $3,515 FABRAZYME Promotional Speaking/Other GENZYME CORPORATION
Mar 6, 2018 $3,330 NO PRODUCT DISCUSSED Consulting GENZYME CORPORATION
Aug 7, 2018 $3,000 VELOPHORO Consulting VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
Sep 14, 2018 $3,000 VELPHORO Promotional Speaking/Other FRESENIUS USA MARKETING, INC.
Jan 31, 2018 $3,000 VELPHORO Promotional Speaking/Other FRESENIUS USA MARKETING, INC.
Jul 25, 2018 $3,000 VELPHORO Promotional Speaking/Other FRESENIUS USA MARKETING, INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/160

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.